OmniAb, Inc.
OABI- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001846253
No open-market purchases or sales by OmniAb, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $144.2M in total; no superinvestor holds it.
Other share classesOABIW
Q3 2022 vs. Q2 2022
How the institutions holding OmniAb, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 1.10M | +1.10M |
| Value | $0 | $11.2M | +$11.2M |
New holders (1)
Institutions that held OmniAb, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 1,101,548 | $11.2M | 0.03% |
Sold out (0)
Institutions that held OmniAb, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.